astragaloside IV has been researched along with spd-304 in 1 studies
| Studies (astragaloside IV) | Trials (astragaloside IV) | Recent Studies (post-2010) (astragaloside IV) | Studies (spd-304) | Trials (spd-304) | Recent Studies (post-2010) (spd-304) |
|---|---|---|---|---|---|
| 5 | 0 | 5 | 18 | 0 | 16 |
| Protein | Taxonomy | astragaloside IV (IC50) | spd-304 (IC50) |
|---|---|---|---|
| Tumor necrosis factor ligand superfamily member 11 | Homo sapiens (human) | 1 | |
| Tumor necrosis factor | Homo sapiens (human) | 1.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Dai, Q; Du, J; Hu, J; Pang, W; Zhang, H | 1 |
1 other study(ies) available for astragaloside IV and spd-304
| Article | Year |
|---|---|
Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
Topics: Antineoplastic Agents; bcl-X Protein; Cell Survival; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Computational Biology; Diosgenin; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Interleukin-2; Killer Cells, Natural; Medicine, Chinese Traditional; Molecular Docking Simulation; Protein Conformation; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2014 |